DeutschNewstral
Article
bizjournals.com on 2021-06-03 14:50
The Petri Dish: Alkermes, Foundation Medicine see FDA approvals
Related news
2019 FDA Precision Medicine Approvals: Progress At FDAjdsupra.com- The Petri Dish: FDA okays cancer drug and Moderna seeks $1.3Bbizjournals.com
- The Petri Dish: Gene therapy deaths, $461M VC fund and Amag's FDA disputebizjournals.com
- The Petri Dish: TransMedics scores FDA approval, two Sanofi Genzyme heads departbizjournals.com
- The Petri Dish: Charles River Labs can't harvest crabs; Apellis gets FDA nodbizjournals.com
- The Petri Dish: Sage, Biogen plan drug application; TV show gets FDA nodbizjournals.com
- The Petri Dish: Novartis-backed startup gets new CEO; FDA approves blood cancer drugbizjournals.com
- The Petri Dish: Biogen exec's new job, Moderna's Covid applications and an FDA warningbizjournals.com
- The Petri Dish: $520M for fibrosis drugs and Sarepta's FDA deadlinebizjournals.com
- The Petri Dish: Trump's FDA commissioner joins Flagship, first patient gets Aduhelmbizjournals.com
- The Petri Dish: Verily's new hire from FDA; Gilead's call to the Hillbizjournals.com
- The Petri Dish: FDA lifts gene therapy hold and PPP recipient raises $100Mbizjournals.com
- The Petri Dish: Flagship startup raises $126M, Binx gets FDA OKbizjournals.com
- The Petri Dish: FDA to fast-track Biogen's next Alzheimer's drugbizjournals.com
- The Petri Dish: Biopharma faces off with FDA and Atlas, 5AM Ventures' new startupbizjournals.com
- The Petri Dish: FDA OK's bluebird trials, Karyopharm loses two execsbizjournals.com
- The Petri Dish: FDA fast-tracks Covid-19 drug, Thermo Fisher acquisitionbizjournals.com
- The Petri Dish: FDA fast-tracks Verastem cancer treatment, Roche veteran joins Praxisbizjournals.com
- The Petri Dish: FDA rejects Biogen drug, a new Covid-19 antibody heads to Phase 3bizjournals.com
- FDA rejects Alkermes' depression drug, questions effectivenessbizjournals.com